How to manage a 34-year-old pregnant woman at 23 weeks gestation with atrial septal defect (ASD) and pulmonary hypertension, currently on tadalafil (phosphodiesterase type 5 inhibitor), who desires to continue the pregnancy and presented with hypoxia and bidirectional shunt?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of a 34-Year-Old Pregnant Woman with ASD and Pulmonary Hypertension

This patient with severe pulmonary hypertension (RVSP 80 mmHg) and ASD with bidirectional shunt should be managed at a tertiary center with PAH expertise, as she faces extremely high maternal mortality risk (17-33% in recent studies) if pregnancy continues. 1

Current Assessment and Diagnosis

  • Diagnosis: Atrial Septal Defect with severe pulmonary arterial hypertension (PAH-CHD) and bidirectional shunt
  • Current status: 23 weeks pregnant, post-extubation hypoxia (SpO2 86%), RVSP 80 mmHg
  • Current therapy: Tadalafil (PDE-5 inhibitor)

Management Plan for Continued Pregnancy

Immediate Actions

  1. Transfer to specialized center: Patient must be transferred to a tertiary center with expertise in PAH and high-risk obstetrics 1

  2. Escalate PAH therapy:

    • Continue tadalafil
    • Consider adding prostacyclin (IV epoprostenol or inhaled iloprost) 1
    • Consider adding endothelin receptor antagonist (ambrisentan) for triple therapy 2
    • Note: Bosentan should be avoided due to teratogenic effects 1
  3. Supplemental oxygen: Maintain maternal oxygen saturation >95% to ensure adequate fetal oxygenation 1, 3

Hospital Management

  1. Positioning: Left lateral positioning to prevent inferior vena cava compression 1, 3

  2. Anticoagulation:

    • Consider LMWH or UFH if indicated for pulmonary thrombosis risk or heart failure signs 1
    • Monitor anti-Xa levels for LMWH or aPTT for UFH 1
  3. Volume management:

    • Maintain adequate circulating volume
    • Avoid systemic hypotension, hypoxia, and acidosis which may precipitate refractory heart failure 1
  4. Monitoring:

    • Daily vital signs with continuous oxygen saturation monitoring
    • Weekly echocardiography to assess pulmonary pressures and right ventricular function
    • Regular assessment of fetal well-being with electronic fetal monitoring 1, 3

Follow-up Plan Until Delivery

  1. Multidisciplinary team involvement:

    • Pulmonary hypertension specialist
    • High-risk obstetrics
    • Neonatology
    • Cardiac anesthesiology
    • Intensive care
  2. Maternal monitoring:

    • Weekly clinical assessment
    • Monthly echocardiography to assess RVSP and right ventricular function
    • Regular arterial blood gases if hypoxemia persists
  3. Fetal monitoring:

    • Regular ultrasound for fetal growth (every 2-3 weeks)
    • Weekly fetal heart rate monitoring
    • Antenatal corticosteroids at 24 weeks for fetal lung maturation
  4. Delivery planning:

    • Target delivery at 32-34 weeks after antenatal corticosteroids
    • Planned cesarean section under regional anesthesia with careful hemodynamic monitoring 1
    • Avoid general anesthesia if possible (risk factor for maternal death) 1
    • Have prostacyclin available for peripartum period 1

Post-delivery Management

  1. Intensive monitoring: ICU admission for at least 72 hours post-delivery 1

    • Highest risk period is immediate postpartum and first few months after delivery
    • Risk of pulmonary hypertensive crisis, pulmonary thrombosis, or refractory right heart failure
  2. Continue PAH therapy: Maintain or escalate PAH-specific therapy as needed 1

  3. Anticoagulation: Consider postpartum thromboprophylaxis 1

Important Considerations and Pitfalls

  1. High maternal mortality risk: The patient must understand that maternal mortality remains high (17-33%) despite optimal management 1

  2. Risk of shunt inversion: Be vigilant for right-to-left shunt worsening, which can cause severe hypoxemia, as reported in similar cases 2

  3. Avoid vasopressors: Use only for intractable hypotension unresponsive to fluid resuscitation due to adverse effects on uteroplacental perfusion 3

  4. Hemodynamic instability: The postpartum period carries the highest risk for decompensation due to fluid shifts and hemodynamic changes 1

  5. Long-term planning: After successful delivery, discuss contraception and future pregnancy avoidance due to extremely high risk 1

The management of this patient represents one of the highest-risk scenarios in pregnancy. Despite the grave prognosis, some case reports have documented successful outcomes with intensive management and multidisciplinary care in specialized centers 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Guidelines for the Management of a Pregnant Trauma Patient.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.